GLP-1 Weight Loss Peptide
Semaglutide:
Complete Protocol Guide
How the compound behind Ozempic and Wegovy actually works, the titration schedule, realistic results, side effect management, and when to consider upgrading to tirzepatide or retatrutide.
01
How Semaglutide Works
Semaglutide is a GLP-1 receptor agonist — a synthetic peptide analogue of GLP-1 (glucagon-like peptide-1), a hormone naturally released by the gut after eating. The body uses GLP-1 to signal satiety to the brain, stimulate insulin secretion, and regulate gastric emptying. Semaglutide mimics and amplifies all of these effects with dramatically extended duration.
Natural GLP-1 has a half-life of 1–2 minutes. Semaglutide — modified with a C18 fatty acid chain and amino acid substitutions — has a half-life of approximately 7 days, allowing a single weekly injection to maintain consistent GLP-1 receptor stimulation. This transforms a transient post-meal signal into a sustained metabolic state change.
Hypothalamic Satiety
GLP-1 receptors in the hypothalamus reduce appetite by suppressing the hunger-signaling neurons that drive caloric intake. Users describe it as "not thinking about food" — appetite suppression at the neurological level.
Delayed Gastric Emptying
Semaglutide significantly slows gastric emptying — food moves through the stomach more slowly, prolonging mechanical fullness after meals. Small meals feel satisfying for hours.
Reward Suppression
GLP-1 receptors in the mesolimbic reward system reduce hedonic eating — the drive to eat for pleasure rather than hunger. Many users report reduced cravings for high-calorie foods specifically.
02
Titration Schedule
Never start at a therapeutic dose. The titration schedule exists to allow GI tolerance to develop — jumping directly to 1mg+ causes severe nausea in most users. Slow and steady dose escalation is not optional.
PHASE
Weeks 1–4
DOSE
0.25mg/week
Induction — receptor exposure, GI tolerance establishment
Minimal weight loss expected. This phase is about tolerability, not efficacy.
PHASE
Weeks 5–8
DOSE
0.5mg/week
Early efficacy — appetite suppression becomes noticeable
Most users begin experiencing meaningful appetite reduction. Weight loss 1–2 lbs/week.
PHASE
Weeks 9–12
DOSE
1.0mg/week
Therapeutic dose — full GLP-1 effect established
Strong appetite suppression and gastric slowing. Accelerated weight loss phase.
PHASE
Weeks 13–16
DOSE
1.7mg/week
Escalated dose — enhanced effect for faster progress
Many users find 1.0–1.7mg their optimal dose range. GI side effects may increase.
PHASE
Week 17+
DOSE
2.4mg/week
Maximum therapeutic dose
FDA-approved ceiling for Wegovy. 14.9% average total weight loss at this dose in trials.
Hold or Slow Down If Needed
If side effects (nausea, vomiting) are intolerable at a new dose level, stay at the previous dose for an additional 4 weeks before escalating. There is no benefit to pushing through severe nausea — it increases dropout risk. Many users find 1.0–1.7mg their personal optimal dose and maintain there indefinitely.
03
Side Effects & Management
Nausea
Very common (44%)The primary reason for slow titration. Eat smaller meals, avoid fatty/spicy foods, stay hydrated. Typically subsides after 4–8 weeks at each dose level.
Severity: Mild to moderate
Constipation
Common (24%)Increase fiber and water intake. Gentle activity helps. Temporary laxative use acceptable if persistent.
Severity: Mild
Diarrhea
Common (30%)Often occurs at dose escalation. Temporary — typically resolves within days of a new dose level. Electrolyte replenishment important.
Severity: Mild
Muscle Loss
Common in rapid weight lossHigh protein intake (1.6–2.2g/kg bodyweight) and resistance training are essential. Many users add CJC-1295/Ipamorelin to preserve lean mass during the cut.
Severity: Manageable with protocol
Fatigue
Common early phaseEnsure adequate caloric intake — too aggressive a deficit amplifies fatigue. Electrolytes (sodium, potassium, magnesium) are often depleted with rapid weight loss.
Severity: Mild
Preserving Muscle Mass on Semaglutide
Rapid caloric restriction from semaglutide-induced appetite suppression risks significant muscle loss alongside fat loss — a common complaint reported in DEXA scan studies. Two protocols dramatically reduce this risk: (1) protein intake of 1.6–2.2g/kg bodyweight daily, prioritized within reduced calorie budget; (2) adding CJC-1295/Ipamorelin to maintain GH pulsatility and anabolic signaling during the cut.
CJC-1295 / Ipamorelin Protocol →04
Semaglutide vs Tirzepatide vs Retatrutide
Semaglutide
14.9%
RECEPTORS
GLP-1R
HALF-LIFE
~7 days
Proven long-term safety record. Best entry point for GLP-1 therapy.
Tirzepatide
20.9%
RECEPTORS
GLP-1R + GIPR
HALF-LIFE
~5 days
Dual agonism — significantly more weight loss than semaglutide. Next step up.
Retatrutide
24.2%
RECEPTORS
GLP-1R + GIPR + GCGR
HALF-LIFE
~6 days
Triple agonism — maximum fat loss. Best body composition effects.
When to Upgrade
Semaglutide is the right starting point for GLP-1 therapy — it has the longest safety record and the most clinical data. If you plateau at maximum semaglutide dose with significant weight still to lose, the evidence consistently supports upgrading to tirzepatide (dual agonist) or retatrutide (triple agonist) for substantially greater efficacy.
Full Three-Way Comparison Guide →Get Semaglutide
Semaglutide
Pharmaceutical-grade lyophilized powder. Certificate of analysis verified. The most clinically proven weight loss peptide available.
Ready to Upgrade?
Tirzepatide and Retatrutide offer significantly greater weight loss for those who need more than semaglutide alone.
06
Frequently Asked Questions
Will I regain weight after stopping semaglutide?
Clinical data shows that most weight is regained after discontinuing semaglutide if lifestyle habits have not changed. The compound manages the hormonal environment for weight loss — it does not create permanent metabolic changes on its own. Successful long-term users either continue maintenance dosing (at lower doses), transition to lifestyle protocols developed during treatment, or cycle on and off with structured diet and training protocols during the off period.
Can I use semaglutide while training for body composition?
Yes — and combining semaglutide with structured resistance training produces significantly better body composition outcomes than semaglutide alone. The key is protecting muscle mass through high protein intake and training stimulus. Adding CJC-1295/Ipamorelin to maintain anabolic signaling during the cut is a common strategy among performance-oriented users.
What happens if I miss a weekly dose?
If you miss a semaglutide dose and it has been less than 5 days since the missed injection, administer it as soon as you remember. If it has been more than 5 days, skip the missed dose and resume on your regular schedule. Do not double dose. Semaglutide's 7-day half-life provides a significant buffer — missing a single dose does not dramatically reduce efficacy.
Is research-grade semaglutide the same as Ozempic/Wegovy?
Research-grade semaglutide is the same molecule (GLP-1 receptor agonist, same amino acid sequence) as pharmaceutical Ozempic and Wegovy. The difference is in manufacturing oversight, QC standards, and regulatory approval. Research-grade semaglutide from reputable suppliers with third-party certificates of analysis is used extensively in clinical research and by knowledgeable self-administering users.
Related Guides
Tirzepatide vs Semaglutide vs Retatrutide →
The complete three-way comparison — which GLP-1 agonist is right for you
Retatrutide Complete Guide →
Triple agonist for maximum fat loss — the next step after semaglutide
CJC-1295 + Ipamorelin →
Add GH optimization to protect muscle mass during semaglutide fat loss
How to Inject Peptides →
Reconstitution, needle selection, and weekly injection technique guide
Body Composition Protocols →
Complete guide to peptide protocols for fat loss and recomposition
All Peptide Guides →
Browse every in-depth protocol and research article
